Stockscreener 앱 받기
1.11
9.90%
0.10
전일 마감가:
$1.01
열려 있는:
$1.09
하루 거래량:
861.03K
Relative Volume:
1.00
시가총액:
$35.58M
수익:
-
순이익/손실:
$-42.37M
주가수익비율:
-1.0387
EPS:
-1.0686
순현금흐름:
$-34.94M
1주 성능:
+48.06%
1개월 성능:
-7.50%
6개월 성능:
-74.72%
1년 성능:
-63.84%
1일 변동 폭
$1.07
$1.15
1주일 범위
$0.731
$1.15
52주 변동 폭
$0.6844
$5.75
Skye Bioscience Inc Stock (SKYE) Company Profile
명칭
Skye Bioscience Inc
전화
(858) 410-0266
주소
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
SKYE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SKYE
Skye Bioscience Inc.
|
3.10 | 12.89M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
3.39 | 4.30B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.92 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.84 | 340.50M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
7.50 | 314.36M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
47.57 | 0 | 0 | 0 | 0 | 0.00 |
Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-06 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2025-08-15 | 개시 | Evercore ISI | Outperform |
| 2025-02-28 | 개시 | William Blair | Outperform |
| 2024-09-30 | 개시 | Scotiabank | Sector Outperform |
| 2024-09-10 | 개시 | JMP Securities | Mkt Outperform |
| 2024-07-09 | 개시 | Craig Hallum | Buy |
| 2024-05-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-04-12 | 개시 | Oppenheimer | Outperform |
모두보기
Skye Bioscience Inc 주식(SKYE)의 최신 뉴스
Lawsuit Alert: Investors who lost money with shares of Skye - openPR.com
A Look At Halozyme Therapeutics (HALO) Valuation After New ENHANZE Obesity Partnership With Skye Bioscience - Yahoo Finance
Burned by Skye Bioscience, Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back - ACCESS Newswire
Levi & Korsinsky Notifies Skye Bioscience, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – SKYE - GlobeNewswire
ROSEN, A TOP-RANKED LAW FIRM, Encourages Skye Bioscience, - GlobeNewswire
SKYE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
SKYE LAWSUIT ALERT: Levi & Korsinsky Notifies Skye Bioscience, Inc. InvestorsLead Plaintiff Deadline January 16, 2026 - ACCESS Newswire
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm - PR Newswire
Lost Money on Skye Bioscience, Inc. (SKYE)? Contact Levi & Korsinsky Before January 16, 2026 to Join Class Action - ACCESS Newswire
HALO, Skye Bioscience team up on obesity drug development - Longevity.Technology
Skye Bioscience, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your RightsSKYE - Finviz
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Portnoy Law Firm Announces Class Action on Behalf of Skye Bioscience, Inc. Investors - GlobeNewswire
Fibonacci Retracement Aligns with Support in Rudra Ecovation LimitedEx-Dividend Date Alerts & Free Long-Term Investment Planning - earlytimes.in
Investors in Skye Bioscience, Inc. (SKYE): Protect Your RightsContact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire
Shareholders of Skye Bioscience, Inc. (SKYE): Protect Your Rights Before January 16, 2026Contact Levi & Korsinsky - ACCESS Newswire
Shareholders SueWallSt in New Class Action Against Skye Bioscience, Inc.Act Now - Stockhouse
Citizens reiterates Market Outperform rating on Skye Bioscience stock By Investing.com - Investing.com Canada
Bronstein, Gewirtz & Grossman LLC Urges Skye Bioscience, - GlobeNewswire
The Gross Law Firm Notifies Shareholders of Skye Bioscience, Inc - GuruFocus
Skye Bioscience shares rise on Halozyme partnership to advance obesity treatment - MSN
Halozyme Therapeutics, Skye Bioscience Collaborate to Evaluate Nimacimab for Obesity Treatment - MarketScreener
Skye Bioscience Licenses Halozyme’s ENHANZE Drug Delivery Technology - Contract Pharma
The Gross Law Firm Notifies Shareholders of Skye Bioscience, Inc.(SKYE) of a Class Action Lawsuit and an Upcoming Deadline - Barchart.com
Skye Bioscience stock jumps after Halozyme collaboration for obesity drug By Investing.com - Investing.com Nigeria
Halozyme Therapeutics (HALO) Partners with Skye Bioscience for I - GuruFocus
Halozyme (HALO) Partners with Skye Bioscience for Obesity Treatm - GuruFocus
Skye Bioscience rises as it partners with Halozyme on obesity drug - TradingView — Track All Markets
Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity - The Manila Times
SKYE ALERT: Securities Fraud Class Action Launched Against Skye Bioscience, Inc.January 16, 2026 Deadline - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Skye Bioscience, Inc. (SKYE) Investors of January 16, 2026 Deadline - ACCESS Newswire
Levi & Korsinsky Urges Skye Bioscience, Inc. (SKYE) Shareholders to Act Before Lead Plaintiff Deadline January 16, 2026 - ACCESS Newswire
Class Action Lawsuit Filed: Skye Bioscience, Inc. (SKYE) – Join by January 16, 2026 – Contact Levi & Korsinsky - ACCESS Newswire
Will Breakout in Rathi Bars Limited Sustain Through Next WeekPortfolio Allocation Tips & Double Or Triple Returns - earlytimes.in
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Your Wyoming Link
Securities Fraud Class Action Filed Against Skye Bioscience, Inc. (SKYE)Levi & Korsinsky Reminds Investors of January 16, 2026 - ACCESS Newswire
Lost Money on Skye Bioscience, Inc.(SKYE)? Join Class Action Sui - GuruFocus
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - FinancialContent
Skye Bioscience, Inc. (SKYE) LawsuitInvestors Urged to Contact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, A TOP RANKED LAW FIRM, Encourages Skye Bioscience, - GlobeNewswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.
Class Action Lawsuit Filed Against Skye Bioscience, Inc. (SKYE)Recover LossesContact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire
Class Action Alert: Levi & Korsinsky Reminds Skye Bioscience, Inc. (SKYE) Investors of January 16, 2026 Deadline - ACCESS Newswire
Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit - GlobeNewswire
Skye Bioscience stock jumps after Halozyme collaboration for obesity drug - Investing.com
Securities Fraud Class Action Filed Against Skye Bioscience, Inc. (SKYE) – Levi & Korsinsky Reminds Investors of January 16, 2026 - ACCESS Newswire
Skye Bioscience, Inc. (SKYE) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire
January 16, 2026 Deadline: Join Class Action Lawsuit Against Skye Bioscience, Inc. (SKYE)Contact Levi & Korsinsky - ACCESS Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit - PR Newswire
Shareholders that lost money on Skye Bioscience, Inc.(SKYE) should contact Levi & Korsinsky about pending Class ActionSKYE - Sahm
Skye Bioscience Inc (SKYE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):